Search results
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks via Yahoo Finance UK· 2 hours agoData from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance UK· 2 hours agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer...
Benzinga via Yahoo Finance UK· 5 hours agoOn Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance UK· 7 hours agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
The Spelthorne General Election candidates vying to get your vote
Surrey Live via Yahoo News UK· 8 hours agoHis exceptional interest in local, national and Geopolitical interest led him to join the Green...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters· 12 hours agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 15 hours agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
London close: Stocks finish lower after Airbus profit warning
ShareCast· 1 day agoLondon stocks ended Tuesday in negative territory, influenced by significant losses in key sectors...
AstraZeneca still a buy for one broker despite mixed Imfinzi data
Proactive Financial News· 1 day agoAstraZeneca PLC (LSE:AZN) has put out mixed data for the Phase III trials of its immuno-oncology...
FTSE 100 movers: Admiral boosted by upgrade; Melrose, Rolls-Royce slump
ShareCast· 1 day agoLondon’s FTSE 100 was down 0.3% at 8,258.89 in afternoon trade on Tuesday.